NEWSROOM

Newly updated for 2024, state report cards herald the end of fibrosis restrictions while warning about needs for parity with managed care organizations and restrictive retreatment policies  FOR IMMEDIATE RELEASE … [Read More]

FOR IMMEDIATE RELEASE   WASHINGTON, D.C. (February 8, 2024) – The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) applaud… [Read More]

Washington, D.C. (August 31, 2023) – The Center for Health Law and Policy Innovation of Harvard Law School (CHLPI) and the National Viral Hepatitis Roundtable (NVHR) today published updates to… [Read More]

FOR IMMEDIATE RELEASE    WASHINGTON, D.C. (June 30, 2023) – In response to disturbing new data released by the Centers for Disease Control and Prevention (CDC), the Center for Health Law… [Read More]

FOR IMMEDIATE RELEASE   WASHINGTON, D.C. (June 12, 2023) – The Center for Health Law & Policy Innovation (CHLPI) of Harvard Law School and the National Viral Hepatitis Roundtable (NVHR) today… [Read More]

FOR IMMEDIATE RELEASE South Dakota Medicaid removes fibrosis and sobriety requirements for hepatitis C treatment With this change, Arkansas is now the only state still requiring proof of liver damage… [Read More]

FOR IMMEDIATE RELEASE  Colorado, Oregon, and Texas Are Lifting Barriers to HCV Treatment for Medicaid Recipients  These states join a growing tide of prior authorization removals for a total of… [Read More]

FOR IMMEDIATE RELEASE Alabama Medicaid removes sobriety requirements for hepatitis C treatment Eliminating the hurdle of abstinence is a big win for people in Alabama with substance use disorders and… [Read More]

FOR IMMEDIATE RELEASE Arizona Medicaid removes prior authorization requirements for hepatitis C treatment Arizona joins 15 states in streamlining access to lifesaving treatment WASHINGTON, D.C. (October 12, 2022) – The… [Read More]

FOR IMMEDIATE RELEASE Washington, D.C. Medicaid Removes Restrictions to Hepatitis C Treatment, Increasing Access for Medicaid Recipients The District of Columbia recently lifted several cumbersome barriers to hepatitis C treatment,… [Read More]

HealthDay: Hepatitis C Infection Can Kill, But Less Than a Third of Patients Get Treatment By Robin Foster and Ernie Mundell | HealthDay | August 10, 2022 WEDNESDAY, Aug. 10,… [Read More]

USA Today: Fewer than a third of insured Americans with hepatitis C receive timely treatment, CDC study shows By Ariana Rodriguez | USA Today | August 9, 2022 More than… [Read More]

FOR IMMEDIATE RELEASE CHLPI & NVHR Statement on New CDC Data Revealing Impact of Insurance Barriers on Hepatitis C Treatment Access WASHINGTON, D.C. (August 9, 2022) – The Center for… [Read More]

FOR IMMEDIATE RELEASE West Virginia Increases Access to Hepatitis C Treatment for State Medicaid Beneficiaries The state recently lifted its prescriber restrictions and sobriety restrictions, joining a growing number of… [Read More]

FOR IMMEDIATE RELEASE Access Denied: CHLPI at Harvard Law School and NVHR Launch New Analysis of How State Medicaid Programs Perpetuate Inequities in Hepatitis C Treatment The Hepatitis C: State… [Read More]

Three state Medicaid programs have eliminated prior authorizations for hepatitis C treatment for most patients, joining a growing number of states to increase access to treatment for Medicaid recipients. WASHINGTON,… [Read More]

The state recently joined a growing number of jurisdictions removing sobriety requirements for hepatitis C treatment, but prescriber requirements remain. WASHINGTON, D.C. (May 24, 2022) – The Center for Health… [Read More]

Virginia and Alaska Improve Access to Hepatitis C Treatment for Medicaid Patients Two state Medicaid programs have eliminated prior authorization requirements for hepatitis C treatment as of January 2022, joining… [Read More]

The state expanded coverage of prior authorization criteria to include all levels of liver scarring and substance use without regard to the specialty of the provider, increasing access to hepatitis… [Read More]

The state removed prior authorizations for two preferred hepatitis C medications, increasing access to hepatitis C treatments for more Rhode Islanders. FOR IMMEDIATE RELEASEAugust 18, 2021 Washington, D.C. – The… [Read More]

Nebraskans covered by Medicaid no longer need to wait until they have advanced liver scarring to receive treatment for hepatitis C; however, stringent sobriety restrictions persist. Washington, D.C. (July 15,… [Read More]

The Wolverine state removed prior authorization requirements for a preferred hepatitis C medication, increasing access to hepatitis C treatment for more Michiganders. Washington, D.C. (April 20, 2021) – The Center for… [Read More]

The two midwestern states removed prior authorizations for first time hepatitis C treatment, increasing opportunities for 130,000 individuals to be treated and cured of hepatitis C. Washington, D.C. (February 22,… [Read More]

New research from NVHR and CHLPI demonstrates that states with sobriety restrictions or state policies that restrict harm reduction services are limiting hepatitis C elimination efforts in the U.S. Washington,… [Read More]

New York State Medicaid recently removed prior authorization requirements for new patients, increasing opportunities for individuals to be treated and cured of hepatitis C. September 21, 2020 – The National Viral… [Read More]

New research finds that hepatitis C treatment restrictions based on alcohol or drug use violate the Americans with Disabilities Act and undermine efforts to end the hepatitis C epidemic. The… [Read More]

Download HCV_State-of-Medicaid-Access_August-2020-update

Iowa Medicaid no longer requires severe liver damage for patients to access hepatitis C treatment, but strict sobriety and prescriber requirements continue to limit treatment availability. July 1, 2020 – The… [Read More]

Increasing access to treatment will help Ohio increase hepatitis C treatment rates for more than 2.6 million Ohioans enrolled in Medicaid. May 21, 2020 – The National Viral Hepatitis Roundtable (NVHR)… [Read More]